Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Non-AIDS-defining hematological malignancies in HIV-infected patients: an epidemiological study in Japan.

Hagiwara S, Yotsumoto M, Odawara T, Ajisawa A, Uehira T, Nagai H, Tanuma J, Okada S.

AIDS. 2013 Jan 14;27(2):279-83. doi: 10.1097/QAD.0b013e32835a5a7a.

PMID:
23014520
2.

Acute myeloid leukaemia in human immunodeficiency virus-infected adults: epidemiology, treatment feasibility and outcome.

Sutton L, Guénel P, Tanguy ML, Rio B, Dhedin N, Casassus P, Lortholary O; French Study Group on Acute Myeloid Leukaemia in HIV-Infected Patients.

Br J Haematol. 2001 Mar;112(4):900-8.

PMID:
11298584
4.

Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.

Gürman G, Arat M, Ilhan O, Konuk N, Beksaç M, Celebi H, Ozcan M, Arslan O, Ustün C, Akan H, Uysal A, Koç H.

Cytotherapy. 2001;3(4):253-60.

PMID:
12171713
5.

Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies. Nagoya CD34+ PBSCT Study Group.

Ogura M, Kagami Y, Suzuki R, Miura K, Uehira K, Kurokawa T, Ito T, Kinoshita T, Emi N, Morishima Y, Kodera Y, Ueda R.

Cancer Chemother Pharmacol. 1997;40 Suppl:S51-7.

PMID:
9272135
6.

Risk of cancers during interrupted antiretroviral therapy in the SMART study.

Silverberg MJ, Neuhaus J, Bower M, Gey D, Hatzakis A, Henry K, Hidalgo J, Lourtau L, Neaton JD, Tambussi G, Abrams DI.

AIDS. 2007 Sep 12;21(14):1957-63.

PMID:
17721103
7.

[High incidence of non-AIDS-defined cancers among HIV-infected patients in Germany. A 3-year nationwide review].

Mosthaf FA, Hanhoff NJ, Goetzenich A, Wolf E, Knechten H.

Dtsch Med Wochenschr. 2006 Aug 25;131(34-35):1849-52. German.

PMID:
16915544
8.

[Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].

Jakó J, Szerafin L, Nagy P.

Orv Hetil. 2005 Mar 6;146(10):461-9. Hungarian.

PMID:
15835344
9.

Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.

Zheng Z, Takahashi M, Aoki S, Toba K, Liu A, Osman Y, Takahashi H, Tsukada N, Suzuki N, Nikkuni K, Furukawa T, Koike T, Aizawa Y.

J Exp Clin Cancer Res. 1998 Sep;17(3):251-8.

PMID:
9894758
10.

Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006-2010): based on registry data from the Japanese Society of Pediatric Hematology.

Horibe K, Saito AM, Takimoto T, Tsuchida M, Manabe A, Shima M, Ohara A, Mizutani S.

Int J Hematol. 2013 Jul;98(1):74-88. doi: 10.1007/s12185-013-1364-2. Epub 2013 May 24.

PMID:
23702913
11.

Intracranial hemorrhage in adult patients with hematological malignancies.

Chen CY, Tai CH, Cheng A, Wu HC, Tsay W, Liu JH, Chen PY, Huang SY, Yao M, Tang JL, Tien HF.

BMC Med. 2012 Aug 29;10:97. doi: 10.1186/1741-7015-10-97.

12.

High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias.

Betticher DC, Fey MF, von Rohr A, Tobler A, Jenzer H, Gratwohl A, Lohri A, Pugin P, Hess U, Pagani O, et al.

Ann Oncol. 1994 Jan;5(1):57-64.

PMID:
7909685
13.
15.

Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.

Azuma T, Tobinai K, Takeyama K, Shibata T, Hidaka M, Kurosawa M, Kasai M, Chou T, Fukushima N, Mukai K, Tsukasaki K, Shimoyama M; Japan Clinical Oncology Group-Lymphoma Study Group (JCOG-LSG), Tokyo, Japan.

Jpn J Clin Oncol. 2012 May;42(5):394-404. doi: 10.1093/jjco/hys029. Epub 2012 Mar 15.

16.

Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in Japan.

Yotsumoto M, Hagiwara S, Ajisawa A, Tanuma J, Uehira T, Nagai H, Fujikawa Y, Maeda S, Kitano K, Arima N, Uno K, Iwai T, Hongo I, Ota Y, Fukutake K, Okada S.

Int J Hematol. 2012 Aug;96(2):247-53. doi: 10.1007/s12185-012-1127-5. Epub 2012 Jul 1.

PMID:
22752537
17.

[Malignant lymphoma associated with HIV infection].

Mitrou PS, Serke M, Pohl C, Becker K, Schrappe-Bächer M, Knauf W, Westerhausen M, Clemens MR, Helm EB, Fischer T, et al.

Dtsch Med Wochenschr. 1991 Aug 16;116(33):1217-23. German.

PMID:
1874122
18.

Spectrum of haematologic malignancies and survival outcomes of adult lymphomas in Maiduguri, north eastern Nigeria--a fourteen year review.

Kagu MB, Ahmed SG, Bukar AA, Mohammed AA, Mayun AA, Musa AB.

Afr J Med Med Sci. 2013 Mar;42(1):5-14.

PMID:
23909089
19.

Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program.

Pagano L, Girmenia C, Mele L, Ricci P, Tosti ME, Nosari A, Buelli M, Picardi M, Allione B, Corvatta L, D'Antonio D, Montillo M, Melillo L, Chierichini A, Cenacchi A, Tonso A, Cudillo L, Candoni A, Savignano C, Bonini A, Martino P, Del Favero A; GIMEMA Infection Program; Gruppo Italiano Malattie Ematologiche dell'Adulto.

Haematologica. 2001 Aug;86(8):862-70.

20.

HIV-1 infection in adults with haematological malignancies in Yaoundé, Cameroon.

Mbanya DN, Minkoulou EM, Kaptue LN.

West Afr J Med. 2002 Jul-Sep;21(3):183-4.

PMID:
12744561
Items per page

Supplemental Content

Write to the Help Desk